REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $394,000 | – | 375,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
READYSTATE ASSET MANAGEMENT LP | 17,500,000 | $21,551,250 | 2.00% |
CSS LLC/IL | 17,325,000 | $21,353,288 | 1.41% |
SSI INVESTMENT MANAGEMENT LLC | 7,938,000 | $9,735,966 | 0.68% |
Boussard & Gavaudan Investment Management LLP | 5,000 | $6,146,212 | 0.58% |
Context Capital Management, LLC | 3,249 | $4,001 | 0.34% |
LINDEN ADVISORS LP | 20,000,000 | $24,645,586 | 0.26% |
AVIVA PLC | 22,325,000 | $27,381,613 | 0.12% |
DeepCurrents Investment Group LLC | 2,384,000 | $2,931,980 | 0.11% |
LAZARD ASSET MANAGEMENT LLC | 35,500,000 | $43,718 | 0.06% |
D. E. Shaw & Co., Inc. | 34,364,000 | $42,380,365 | 0.04% |